James T. Rosenbaum, MD
James T. Rosenbaum, M.D.
Professor of Ophthalmology, Medicine, and Cell Biology, OHSU
Head, Division of Arthritis and Rheumatic Diseases, OHSU
Edward E Rosenbaum Professor of Inflammation Research
Education and Training
Medical School: Yale University
IM Residency: Stanford Medical Center
Rheumatology Fellowship: Stanford Medical Center (mentor: Hugh McDevitt)
James T. Rosenbaum has spent more than 30 years studying ocular inflammatory disease including animal models of uveitis. His research interests are complemented by his direction of a clinic devoted to patients with ocular inflammatory diseases including uveitis, scleritis, orbital inflammation, and steroid sensitive optic neuropathy. He has authored more than 350 peer reviewed publications and more than 75 chapters or invited publications. He has been honored by the Association for Research in Vision and Ophthalmology and by the International Uveitis Study Group Eye Foundation with their highest awards.
- Rosenbaum JT. Eyeing macular degeneration--few inflammatory remarks. N Engl J Med. 2012 Aug 23; 367(8):768-70. doi: 10.1056/NEJMcibr1204973.
- Rosenbaum JT, Ku J, Ali A, Choi D, Suhler EB. Patients with retinal vasculitis rarely suffer from systemic vasculitis. Semin Arthritis Rheum. 2012 Jun; 41(6):859-65. doi: 10.1016/j.semarthrit.2011.10.006. Epub 2011 Dec 15.
- Rosenbaum JT, Davey MP. Time for a gut check: evidence for the hypothesis that HLA-B27 predisposes to ankylosing spondylitis by altering the microbiome. Arthritis Rheum. 2011 Nov; 63(11):3195-8. doi: 10.1002/art.30558.